257 related articles for article (PubMed ID: 23095351)
1. Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care.
Stamuli E; Bloor K; MacPherson H; Tilbrook H; Stuardi T; Brabyn S; Torgerson D
BMC Gastroenterol; 2012 Oct; 12():149. PubMed ID: 23095351
[TBL] [Abstract][Full Text] [Related]
2. Acupuncture for irritable bowel syndrome: a protocol for a pragmatic randomised controlled trial.
MacPherson H; Bland M; Bloor K; Cox H; Geddes D; Kang'ombe A; Reynolds J; Stamuli E; Stuardi T; Tilbrook H; Torgerson D; Whorwell P
BMC Gastroenterol; 2010 Jun; 10():63. PubMed ID: 20565790
[TBL] [Abstract][Full Text] [Related]
3. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
4. Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial.
MacPherson H; Tilbrook H; Bland JM; Bloor K; Brabyn S; Cox H; Kang'ombe AR; Man MS; Stuardi T; Torgerson D; Watt I; Whorwell P
BMC Gastroenterol; 2012 Oct; 12():150. PubMed ID: 23095376
[TBL] [Abstract][Full Text] [Related]
5. Acupuncture for irritable bowel syndrome an exploratory randomised controlled trial.
Reynolds JA; Bland JM; MacPherson H
Acupunct Med; 2008 Mar; 26(1):8-16. PubMed ID: 18356794
[TBL] [Abstract][Full Text] [Related]
6. Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomised controlled trial.
MacPherson H; Tilbrook H; Agbedjro D; Buckley H; Hewitt C; Frost C
Acupunct Med; 2017 Mar; 35(1):17-23. PubMed ID: 26980547
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of acupuncture care as an adjunct to exercise-based physical therapy for osteoarthritis of the knee.
Whitehurst DG; Bryan S; Hay EM; Thomas E; Young J; Foster NE
Phys Ther; 2011 May; 91(5):630-41. PubMed ID: 21415230
[TBL] [Abstract][Full Text] [Related]
8. Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.
Vickers AJ; Rees RW; Zollman CE; McCarney R; Smith CM; Ellis N; Fisher P; Van Haselen R; Wonderling D; Grieve R
Health Technol Assess; 2004 Nov; 8(48):iii, 1-35. PubMed ID: 15527670
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial.
McCrone P; Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
BMC Gastroenterol; 2021 Jul; 21(1):276. PubMed ID: 34229619
[TBL] [Abstract][Full Text] [Related]
10. Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.
Everitt H; Landau S; Little P; Bishop FL; McCrone P; O'Reilly G; Coleman N; Logan R; Chalder T; Moss-Morris R;
BMJ Open; 2015 Jul; 5(7):e008622. PubMed ID: 26179651
[TBL] [Abstract][Full Text] [Related]
11. Acupuncture for treatment of irritable bowel syndrome.
Manheimer E; Cheng K; Wieland LS; Min LS; Shen X; Berman BM; Lao L
Cochrane Database Syst Rev; 2012 May; 5(5):CD005111. PubMed ID: 22592702
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.
Fisher M; Walker A; Falqués M; Moya M; Rance M; Taylor D; Lindner L
Eur J Health Econ; 2016 Dec; 17(9):1091-1100. PubMed ID: 26728984
[TBL] [Abstract][Full Text] [Related]
13. Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.
Thomas KJ; MacPherson H; Ratcliffe J; Thorpe L; Brazier J; Campbell M; Fitter M; Roman M; Walters S; Nicholl JP
Health Technol Assess; 2005 Aug; 9(32):iii-iv, ix-x, 1-109. PubMed ID: 16095547
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.
Williams NH; Edwards RT; Linck P; Muntz R; Hibbs R; Wilkinson C; Russell I; Russell D; Hounsome B
Fam Pract; 2004 Dec; 21(6):643-50. PubMed ID: 15531626
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy.
Molassiotis A; Dawkins B; Longo R; Suen LK; Cheng HL; Mok T; Hulme CT; Yeo W
Acupunct Med; 2021 Feb; 39(1):41-52. PubMed ID: 32404001
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of acupuncture compared with usual care for acute non-specific low back pain: secondary analysis of a randomised controlled trial.
Skonnord T; Fetveit A; Skjeie H; Brekke M; Grotle M; Klovning A; Aas E
Acupunct Med; 2022 Apr; 40(2):123-132. PubMed ID: 34847780
[TBL] [Abstract][Full Text] [Related]
17. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome.
Sampaio F; Bonnert M; Olén O; Hedman E; Lalouni M; Lenhard F; Ljótsson B; Ssegonja R; Serlachius E; Feldman I
BMJ Open; 2019 Jan; 9(1):e023881. PubMed ID: 30679293
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.
Pyne S; Sach TH; Lawrence M; Renz S; Eminton Z; Stuart B; Thomas KS; Francis N; Soulsby I; Thomas K; Permyakova NV; Ridd MJ; Little P; Muller I; Nuttall J; Griffiths G; Layton AM; Santer M
BMJ Open; 2023 Dec; 13(12):e073245. PubMed ID: 38081673
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of habit-based advice for weight control versus usual care in general practice in the Ten Top Tips (10TT) trial: economic evaluation based on a randomised controlled trial.
Patel N; Beeken RJ; Leurent B; Omar RZ; Nazareth I; Morris S
BMJ Open; 2018 Aug; 8(8):e017511. PubMed ID: 30104307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
